期刊文献+

注射吸毒人群HCV感染相关因素的分析 被引量:3

Correlated Factors of Hepatitis C Virus Infection among Injection Drug Users
原文传递
导出
摘要 为了探讨注射吸毒人群丙型肝炎病毒(HCV)感染的影响因素,以2006~2008年江苏省5市部分戒毒所、劳教所新入的1 358例注射吸毒人员为调查对象。对调查对象进行问卷调查,采血并对血液标本行ELISA法检测抗-HCV,数据用SPSS13.0行单因素和多因素分析。1 358例注射吸毒者中共检测出HCV抗体阳性者798例,阳性率为58.8%;男性注射吸毒者易感染HCV(χ2=8.30,P〈0.05);随着年龄的增长HCV的感染率呈下降趋势(χ2=11.87,P〈0.05);共用注射器、注射吸毒时间大于10年、商业性性行为是该人群HCV感染的危险因素。注射吸毒人群中HCV感染率远高于一般人群,说明该人群是HCV防治重点人群。因此,对该人群HCV感染的危险因素需进行针对的健康教育和行为干预综合防治措施。 The purpose is to explore the correlated factors of hepatitis C virus infection among injection drug users(IDUs).A total of 1358 IDUs were surveyed,who were newly locked up during April to June in 2006~2008 at 5 sentinel sites,which were established as parts of detoxification centers and reeducation centers of Jiangsu Province.Besides the questionnaires survey,intravenous blood samples were also taken for HCV antibody test with ELASA.Univariate and multivariate analysis were performed by SPSS13.0 based on cleaned data.Among 1358 IDUs,798 were HCV positive cases,with the rate being 58.8%.Compared with female,male are more tend to infect HCV(χ2=8.30,P0.05).Also the younger IDUs have more opportunities to get HCV(χ2=11.87,P0.05).Syringe sharing,more than 10 years of injecting drug use and commercial sexual behavior were correlated to HCV infection.The positive rate of HCV infection among IDUs was greatly higher than that of the general people,which tells us that a great attention should be paid to them.Furthermore,more targeted health education,behavioral intervention integrated prevention and control measures should be taken immediately.
出处 《药物生物技术》 CAS CSCD 2011年第1期61-65,共5页 Pharmaceutical Biotechnology
基金 国家自然科学基金资助项目(30972628)
关键词 注射吸毒 丙型肝炎病毒 多因素分析 Hepatitis C virus Injecting drug users Multivariate analysis
  • 相关文献

参考文献10

  • 1National Narcotic Control Commission[R]. Anal Report on Drug Control in China (Beijing, NNCC), 2006.
  • 2Xia X, Luo J, Bed J, et al. Epidemiology of hepatitis C virus in fection among injection drug users in China: systematic review and meta-analysis[J]. Public Health, 2008,122(10) :990.
  • 3Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepa titis C virus infection [J]. Lancet Infect Dis, 2005,5:558.
  • 4李立明.流行病学[M].北京:人民卫生出版社,2005:533—535.
  • 5Hiraga K, Mizuguchi T, Takeda F. The incidence of cancer pain and the improvement in pain management in Japan [J].Postgrad Med J , 1991,67(2) :14.
  • 6Todd CS, Abed AM, Strathdee SA, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan [J]. Emerg Infect Dis, 2007,13:1327.
  • 7Stark K, Muller R, Bienzle U, et al. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin [J]. AIDS, 1996,10:311.
  • 8Haqan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C viruses [J].AmJ Epidemiol, 1999,149 : 203.
  • 9Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta analysis [J]. Clin Infect Dis, 2001,33 : 562.
  • 10Thomas PG, Jennifer RK, Julimme S, etal. Cirrhosis and hepatocellular carcinoma in HIV infected veterans with and without the Hepatitis C Virus [J]. Arch Intern Med, 2004,164:2349.

共引文献16

同被引文献60

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部